{"slideshow_credits": null, "snippet": "Mylan is taking advantage of Dutch takeover defenses to block a hostile bid by Teva Pharmaceuticals, but U.S. market rules may hamper its efforts.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"lastname": "SOLOMON", "rank": 1, "firstname": "Steven", "role": "reported", "organization": "", "middlename": "Davidoff"}], "original": "By STEVEN DAVIDOFF SOLOMON"}, "web_url": "http://www.nytimes.com/2015/06/12/business/dealbook/mylans-dutch-takeover-defense-is-in-nasdaqs-hands.html", "lead_paragraph": "Mylan is taking advantage of Dutch takeover defenses to block a hostile bid by Teva Pharmaceuticals, but U.S. market rules may hamper its efforts.", "headline": {"main": "Mylan\u2019s Dutch Takeover Defense Is in Nasdaq\u2019s Hands", "content_kicker": "Deal Professor", "kicker": "Deal Professor"}, "_id": "5579ea8538f0d82bd01b4ff9", "word_count": "1468", "multimedia": [{"height": 126, "url": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 601, "url": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof-drug-articleLarge-v3.jpg", "legacy": {"xlarge": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof-drug-articleLarge-v3.jpg", "xlargewidth": "600", "xlargeheight": "601"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof3-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof3-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-06-12T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "1"}, {"name": "organizations", "value": "Mylan Inc", "is_major": "N", "rank": "2"}, {"name": "organizations", "value": "Perrigo Company", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "NASDAQ OMX Group Inc", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "Teva Pharmaceutical Industries Ltd", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Shareholder Rights and Activism", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}